<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Mol Life Sci</journal-id><journal-id journal-id-type="iso-abbrev">Cell Mol Life Sci</journal-id><journal-id journal-id-type="pmc-domain-id">4579</journal-id><journal-id journal-id-type="pmc-domain">cmls</journal-id><journal-title-group><journal-title>Cellular and Molecular Life Sciences: CMLS</journal-title></journal-title-group><issn pub-type="ppub">1420-682X</issn><issn pub-type="epub">1420-9071</issn><publisher><publisher-name>Springer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11113570</article-id><article-id pub-id-type="pmcid-ver">PMC11113570.1</article-id><article-id pub-id-type="pmcaid">11113570</article-id><article-id pub-id-type="pmcaiid">11113570</article-id><article-id pub-id-type="pmid">25323132</article-id><article-id pub-id-type="doi">10.1007/s00018-014-1756-3</article-id><article-id pub-id-type="publisher-id">1756</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Steinbach</surname><given-names initials="JM">Jill M.</given-names></name><address><phone>(502) 852-5486</phone><email>jill.steinbach@louisville.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.266623.5</institution-id><institution-id institution-id-type="ISNI">0000000121131622</institution-id><institution>Department of Bioengineering, </institution><institution>Center for Predictive Medicine, University of Louisville, </institution></institution-wrap>505 S. Hancock St., CTRB, Room 623, Louisville, KY 40202 USA </aff></contrib-group><pub-date pub-type="epub"><day>17</day><month>10</month><year>2014</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2015</year></pub-date><volume>72</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">463023</issue-id><fpage>469</fpage><lpage>503</lpage><history><date date-type="received"><day>28</day><month>2</month><year>2014</year></date><date date-type="rev-recd"><day>10</day><month>9</month><year>2014</year></date><date date-type="accepted"><day>6</day><month>10</month><year>2014</year></date></history><pub-history><event event-type="pmc-release"><date><day>17</day><month>10</month><year>2014</year></date></event><event event-type="pmc-live"><date><day>24</day><month>05</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-05-24 10:25:12.527"><day>24</day><month>05</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; Springer Basel 2014</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="18_2014_Article_1756.pdf"/><abstract id="Abs1"><p>Intravaginal delivery offers an effective option for localized, targeted, and potent microbicide delivery. However, an understanding of the physiological factors that impact intravaginal delivery must be considered to develop the next&#160;generation of microbicides. In this review, a comprehensive discussion of the opportunities and challenges of intravaginal delivery are highlighted, in the context of the intravaginal environment and currently utilized dosage forms. After a subsequent discussion of the stages of microbicide development, the intravaginal delivery of proteins and oligonucleotides is addressed, with specific application to HSV and HIV. Future directions may include the integration of more targeted delivery modalities to virus and host cells, in addition to the use of biological agents to affect specific genes and proteins involved in infection. More versatile and multipurpose solutions are envisioned that integrate new biologicals and materials into potentially synergistic combinations to achieve these goals.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Intravaginal</kwd><kwd>Microbicides</kwd><kwd>Drug delivery</kwd><kwd>Gene delivery</kwd><kwd>Protein delivery</kwd><kwd>Sexually transmitted infection (STI)</kwd><kwd>HIV</kwd><kwd>HSV</kwd><kwd>Intravaginal ring (IVR)</kwd><kwd>Nanoparticles</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Basel 2015</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>